Welldoc announced its strategic partnership with Redox Inc., which will allow providers to receive and review insights about users of the BlueStar digital health app for diabetes management directly within their electronic health record (EHR) at the point of care.
With a shared vision to improve health outcomes of patients and alleviate physician burden, Welldoc and Redox are positioned to optimize clinical decision support by making more patient data available in real time.
“To be successful, digital health solutions require frictionless data flow for the consumer and clinicians. We have done that for the consumer with integrations into their devices,” said Welldoc Chief Strategy Officer Anand Iyer. “Redox has taken an inside-out approach with the interoperability of EHRs, which is why we are excited to partner with them. Together, we are paving the way for the entire industry.”
With one in four American adults managing multiple chronic conditions today, patients are seeking ways to better self-manage health outside of the clinical setting. BlueStar provides precise, AI-based real-time feedback focused on engaging patients to manage their health with clinical decision support.
Welldoc’s digital health tools work with the Redox network to ensure products are capable and securely executing meaningful, bidirectional integration workflows with a vendor-agnostic platform for healthcare data exchange. Through this partnership, Welldoc’s BlueStar is immediately interoperable with any organization using Redox for healthcare data exchange to optimize the provider and patient experience.
